Clinical trial
Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast…
NCT00002544 · Arbeitsgemeinschaft fur Internistische Onkologie, Other · Completed
Key facts
| NCT number | NCT00002544 |
|---|---|
| Title | Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer |
| Official title | MITOXANTRONE (N) VS. 5-FLUOROURACIL, EPIRUBICIN AND CYCLOPHOSPHAMIDE AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC BREAST CANCER AND AN UNFAVORABLE PROGNOSIS |
| Lead sponsor | Arbeitsgemeinschaft fur Internistische Onkologie, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, mitoxantrone hydrochloride |
| Enrollment | 300 |
| Start date | May 1, 1993 |
| Completion | Nov 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: